Synairgen plc
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein, which orchestrates the body's antiviral responses. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the Unit… Read more
Market Cap & Net Worth: Synairgen plc (SYGGF)
Synairgen plc (PINK:SYGGF) has a market capitalization of $12.13 Million ($12.13 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #44801 globally and #14157 in its home market, demonstrating a -15.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Synairgen plc's stock price $0.01 by its total outstanding shares 1102660697 (1.10 Billion).
Synairgen plc Market Cap History: 2020 to 2025
Synairgen plc's market capitalization history from 2020 to 2025. Data shows change from $2.21 Billion to $12.13 Million (-70.30% CAGR).
Synairgen plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Synairgen plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SYGGF by Market Capitalization
Companies near Synairgen plc in the global market cap rankings as of March 18, 2026.
Key companies related to Synairgen plc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Synairgen plc Historical Marketcap From 2020 to 2025
Between 2020 and today, Synairgen plc's market cap moved from $2.21 Billion to $ 12.13 Million, with a yearly change of -70.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $12.13 Million | -83.82% |
| 2024 | $74.98 Million | +36.00% |
| 2023 | $55.13 Million | -59.68% |
| 2022 | $136.73 Million | -95.55% |
| 2021 | $3.07 Billion | +39.25% |
| 2020 | $2.21 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Synairgen plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.13 Million USD |
| MoneyControl | $12.13 Million USD |
| MarketWatch | $12.13 Million USD |
| marketcap.company | $12.13 Million USD |
| Reuters | $12.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.